Brand Name
Zevtera
Generic Name
Ceftobiprole Medocaril
View Brand Information FDA approval date: April 01, 2025
Classification: Cephalosporin Antibacterial
Form: Injection
What is Zevtera (Ceftobiprole Medocaril)?
ZEVTERA is a cephalosporin antibacterial indicated for the treatment of: Adult patients with Staphylococcus aureus bloodstream infections , including those with right-sided infective endocarditis.
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment